HK1257238A1 - 預防和治療脂質腎損傷的藥物及其用途 - Google Patents

預防和治療脂質腎損傷的藥物及其用途

Info

Publication number
HK1257238A1
HK1257238A1 HK18116274.3A HK18116274A HK1257238A1 HK 1257238 A1 HK1257238 A1 HK 1257238A1 HK 18116274 A HK18116274 A HK 18116274A HK 1257238 A1 HK1257238 A1 HK 1257238A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
kidney injury
treating lipid
lipid kidney
Prior art date
Application number
HK18116274.3A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257238A1 publication Critical patent/HK1257238A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18116274.3A 2016-12-15 2018-12-19 預防和治療脂質腎損傷的藥物及其用途 HK1257238A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201611162257 2016-12-15
CN201611161347 2016-12-15
CN201611162237 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257238A1 true HK1257238A1 (zh) 2019-10-18

Family

ID=62658103

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116274.3A HK1257238A1 (zh) 2016-12-15 2018-12-19 預防和治療脂質腎損傷的藥物及其用途

Country Status (2)

Country Link
CN (1) CN108210909A (zh)
HK (1) HK1257238A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201902419D0 (en) * 2019-02-22 2019-04-10 Singapore Health Serv Pte Ltd Treatment of kidney injury
EP4112069A4 (en) * 2020-02-26 2023-09-27 Talengen International Limited METHOD AND MEDICINE FOR THE PREVENTION AND TREATMENT OF AN ABNORMAL BLOOD PRESSURE PROBLEM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2914575B1 (en) * 2012-10-31 2020-10-14 The Regents Of The University Of Michigan Plasminogen activator-1 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
CN108210909A (zh) 2018-06-29

Similar Documents

Publication Publication Date Title
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
IL258854A (en) Preparations containing cannabidiol and secondary medicinal agents for cancer treatment
IL260771B1 (en) Catheter closure solution and catheter closure treatment
SI3227237T1 (sl) Naprava in njena uporaba za UV-obdelavo fluidov
HK1259545A1 (zh) 用於治療癌症的bcl-2抑制劑和mek抑制劑組合產品
EP3544654C0 (de) Vorrichtung für die repetitive zu- und ableitung von substanzen für die medizinische therapie
HK1257239A1 (zh) 預防和治療肥胖症的藥物及其用途
GB201617064D0 (en) Compounds and their therapeutic use
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use
HK1257585A1 (zh) 預防和治療皮膚纖維化的藥物及其用途
IL259035A (en) Oxadiazaspiro compounds for the treatment of abuse and drug addiction
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
EP3723742C0 (fr) Utilisation de la fluoroethylnormemantine pour la prevention et le traitement de l'anxiete
HK1257238A1 (zh) 預防和治療脂質腎損傷的藥物及其用途
EP3156054A4 (en) Medicine for preventing and/or treating stress-induced diseases
HK1257590A1 (zh) 預防和治療藥物性腎損傷的藥物及其用途
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
IL251407A0 (en) A multivalent compound for the treatment and prevention of brain damage
EP3490604C0 (en) MEDICATION FOR THE TREATMENT AND/OR PREVENTION OF ENDOMETRIOSIS
HK1251178A1 (zh) 用於預防由放射療法引起的皮膚損傷的可樂定和/或可樂定衍生物